BridgeMD
Compares treatment options for Chronic Kidney Disease Requiring Hemodialysis
Official title Effect of Zinc Supplementation on Hyperhomocysteinemia Compared to Folic Acid in CKD Patient on Hemodialysis
ClinicalTrials.gov ID: NCT06847139
What this study is testing
What is Zinc Sulfate 50 Mg Tab?
Zinc Sulfate 50 Mg Tab is an investigational medicine, being studied as a potential treatment for chronic kidney disease requiring hemodialysis.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Hyperhomocysteinemia is a well-recognized risk factor for accelerated cardiovascular events in hemodialysis patients. Hyperhomocysteinemia is common in individuals with chronic kidney disease (CKD).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- 1\. Age ≥18 years 2. Patient with chronic kidney disease on HD for ≥ 3 months 3. Plasma homocysteine level \> 15μmol/L
You likely can't join if
- Acute illness at the time of inclusion.
- Diagnosed case of malabsorption
- Planned major surgery
- Renal transplantation
- Receiving zinc or folic acid supplementation within the previous month from enrollment.
- Concomitant use of vitamin B 12 supplementation(6 days), corticosteroid (18-36 hour), anti folate or cytotoxic drugs, quinolones, tetracyclines...
See the full eligibility criteria
- 1\. Age ≥18 years 2. Patient with chronic kidney disease on HD for ≥ 3 months 3. Plasma homocysteine level \> 15μmol/L
- Acute illness at the time of inclusion.
- Diagnosed case of malabsorption
- Planned major surgery
- Renal transplantation
- Receiving zinc or folic acid supplementation within the previous month from enrollment.
- Concomitant use of vitamin B 12 supplementation(6 days), corticosteroid (18-36 hour), anti folate or cytotoxic drugs, quinolones, tetracyclines, bisphosphonates.
- Known hypersensitivity to zinc or folic acid. \-
The study team makes the final eligibility decision.
Where it's taking place
- Chittagong, Bangladesh
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chittagong, Bangladesh. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.